P27 ROLE OF CORTICOSTEROID THERAPY IN IgA NEPHROPATHY - WHERE DO WE STAND?

P27 ROLE OF CORTICOSTEROID THERAPY IN IgA NEPHROPATHY - WHERE DO WE STAND?

Bibliographic Details
Main Authors:	S.P. Nagaraju, A.S. Mareddy, A.R. Prabhu, D. Rangaswamy, M. madken, S. Rao, S. Kaza, U.V. Mateti, V. Guddattu, S.L. Koulmane Laxminarayana
Format:	Article
Language:	English
Published:	Elsevier 2016-11-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024916301127

Similar Items

Role of corticosteroid therapy in IgA nephropathy; where do we stand?
by: Shankar Prasad Nagaraju, et al.
Published: (2017-10-01)

Impact of body mass index on progression of primary immunoglobulin a nephropathy
by: Shankar Prasad Nagaraju, et al.
Published: (2018-01-01)

Efficacy and safety of a modified- ‘modified Ponticelli’ regimen for treatment of primary membranous nephropathy
by: Indu Ramachandra Rao, et al.
Published: (2019-07-01)

Pulmonary thromboembolism as first presentation of childhood membranous nephropathy
by: Mohit Madken, et al.
Published: (2017-01-01)

Corticosteroid therapy in IgA Nephropathy: A friend or foe?
by: Dana Kim, et al.
Published: (2023-03-01)

Severe Adverse Effects Associated With Corticosteroid Treatment in Patients With IgA Nephropathy
by: Qingqing Cai, et al.
Published: (2017-07-01)

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.
by: Cristina Sarcina, et al.
Published: (2016-01-01)

Comparative analysis between the safety and efficacy of oral corticosteroids versus corticosteroids pulse therapies in IgA nephropathy
by: Yu Wang, et al.
Published: (2023-12-01)

Acute Kidney Injury and Progressive Diabetic Kidney Disease: An Epidemiological Perspective
by: Prabhu RA, et al.
Published: (2021-02-01)

Novel cell population data in Unicel DXH800 in the diagnosis of early sepsis
by: R. Bhattacharya, et al.
Published: (2020-12-01)

Hematological and biochemical parameters to differentiate between Kyasanur forest disease and Dengue hemorrhagic fever
by: R. Nair, et al.
Published: (2020-12-01)

Iga nephropathy
by: Basta-Jovanović Gordana M.
Published: (2004-01-01)

The Non-Coding RNA Landscape in IgA Nephropathy—Where Are We in 2021?
by: Izabella Z. A. Pawluczyk, et al.
Published: (2021-05-01)

Albumin-to-fibrinogen ratio is an independent predictor of corticosteroid response and prognosis in patients with IgA nephropathy
by: Yu Zhang, et al.
Published: (2023-04-01)

Associations of corticosteroid therapy and tonsillectomy with kidney survival in a multicenter prospective study for IgA nephropathy
by: Tetsuya Kawamura, et al.
Published: (2023-10-01)

Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study
by: Ya-zi Yang, et al.
Published: (2019-08-01)

The effectiveness and safety of corticosteroid therapy for IgA nephropathy with crescents: a prospective, randomized, controlled study
by: Mengjun Liang, et al.
Published: (2022-01-01)

IgA nephropathy relapse following COVID-19 vaccination treated with corticosteroid therapy: case report
by: Shota Watanabe, et al.
Published: (2022-04-01)

The Supportive Treatment of IgA Nephropathy and Idiopathic Nephrotic Syndrome: How Useful are Omega-3 Polyunsaturated Fatty Acids?
by: Uwaezuoke SN, et al.
Published: (2020-02-01)

Comparison between hydroxychloroquine and systemic corticosteroids in IgA nephropathy: a two-year follow-up study
by: Feng-Lei Si, et al.
Published: (2023-06-01)

Clinical efficacy and safety of full-dose versus half-dose corticosteroids plus leflunomide for IgA nephropathy
by: Yebei Li, et al.
Published: (2021-11-01)

Corticosteroids in IgA nephropathy: Daily oral or intravenous pulses followed by every other day oral administration
by: Revela Ioanna, et al.
Published: (2015-01-01)

Abnormal Aspects of IgA in IgA Nephropathy
by: Akash Nabil, et al.
Published: (2000-01-01)

Immunosupression in IgA Nephropathy
by: Ileana Peride, et al.
Published: (2022-03-01)

P07 SHOULD PATIENTS UNDERGOING RENAL TRANSPLANT WITHOUT INDUCTION WITH BIOLOGIC AGENTS, RECEIVE CYTOMEGALOVIRUS CHEMOPROPHYLAXIS?
by: D. Rangaswamy, et al.
Published: (2016-11-01)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
by: Manliu Wang, et al.
Published: (2020-02-01)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
by: Marios Papasotiriou, et al.
Published: (2022-02-01)

The effectiveness and safety of full-dose half-dose corticosteroid plus renin-angiotensin system blockers for IgA nephropathy
by: Li Wang, et al.
Published: (2019-11-01)

Efficacy and safety of leflunomide combined with corticosteroids for the treatment of IgA nephropathy: a Meta-analysis of randomized controlled trials
by: Guangxin Lv, et al.
Published: (2022-12-01)

Corticosteroids Improve Renal Survival: A Retrospective Analysis From Chinese Patients With Early-Stage IgA Nephropathy
by: Aiya Qin, et al.
Published: (2020-10-01)

IgA Vasculitis and IgA Nephropathy: Same Disease?
by: Evangeline Pillebout
Published: (2021-05-01)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
by: Maciej Tota, et al.
Published: (2023-04-01)

Role of the intestinal MALT in pathogenesis of the IgA-nephropathy
by: Sergei V. Guliaev, et al.
Published: (2021-06-01)

Bortezomib for Reduction of Proteinuria in IgA Nephropathy
by: Choli Hartono, et al.
Published: (2018-07-01)

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
by: Jia-Wei He, et al.
Published: (2022-03-01)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
by: Pei Chen, et al.
Published: (2018-10-01)

Hemosiderin tubulopathy-induced acute kidney injury - A rare initial manifestation of paroxysmal nocturnal hemoglobinuria
by: Srikanth Prasad Rao, et al.
Published: (2018-01-01)

Efficacy and safety of low-dose corticosteroids combined with leflunomide for progressive IgA nephropathy: a systematic review and meta-analysis
by: Dongxu Zhang, et al.
Published: (2024-03-01)

An Update on the Genetics of IgA Nephropathy
by: Lin-Lin Xu, et al.
Published: (2023-12-01)

Hyperuricemia Aggravates IgA Nephropathy
by: Mahmoud Rafieian-Kopaei, et al.
Published: (2013-11-01)